Keywords:
Costello syndrome; Noonan syndrome; cardio-facio-cutaneus syndrome; neurofibromatosis; signaling; therapeutics
Abstract:
Germline pathogenic variants in the RAS/mitogen-activated protein kinase (MAPK) signaling pathway are the molecular cause of RASopathies, a group of clinically overlapping genetic syndromes.